89bio, Inc. (ETNB) Net Cash Provided by (Used in) Financing Activities USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
89bio, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • 89bio, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $21 M, a 93.5% decline year-over-year.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $513 M, a 335% increase from 2022.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $118 M, a 394% increase from 2021.
  • 89bio, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $23.9 M, a 84.9% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $513 M +$395 M +335% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $118 M +$94 M +394% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $23.9 M -$134 M -84.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-01
2020 $158 M +$50.2 M +46.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $108 M +$83.9 M +353% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $23.8 M Jan 18, 2018 Dec 31, 2018 10-K 2020-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.